Reckitt, Generics Makers Settle Mucinex Antitrust Case

Law360, Los Angeles (November 29, 2017, 10:15 PM EST) -- Reckitt Benckiser Inc. has reached a settlement with a generic-drug maker that had accused the British company of unfairly cutting out competition for an extended-release version of Mucinex by violating a patent infringement settlement agreement they’d struck, according to a judgment Tuesday ending the Pennsylvania federal court case.

Reckitt resolved a two-year dispute with Mutual Pharmaceuticals Co. and related companies over whether Reckitt violated a 2007 settlement agreement in a patent suit over the formula that backs Mucinex, called extended-release guaifenesin, after nearly a year of...
To view the full article, register now.